Enovis Corporation ENOV
26.23 USD -0.87 (-3.21%)
Regular-session close
26.23 0.00 0.00%
After hours · Nov 19, 4:07 PM ET
25.97 Day range 27.53
16.70 52-week range 31.67
- YTD
- -1.54%
- 1 year
- -3.46%
News
globenewswire.com Enovis to Present at the Annual Jefferies Global Healthcare Concerence in London Dallas, TX, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced that members of the Enovis management team will…
marketbeat.com What Enovis (ENOV) Said on Its Q3 Earnings Call Enovis NYSE: ENOV reported third-quarter sales of $559 million and raised its full-year adjusted earnings outlook, as growth in its reconstructive business and improved cash generation helped offset…benzinga.com Canaccord Genuity Maintains Buy on Enovis, Lowers Price Target to $42 Canaccord Genuity analyst Caitlin Cronin maintains Enovis (NYSE:ENOV) with a Buy and lowers the price target from $45 to $42.
benzinga.com Evercore ISI Group Maintains Outperform on Enovis, Raises Price Target to $33 Evercore ISI Group analyst Vijay Kumar maintains Enovis (NYSE:ENOV) with a Outperform and raises the price target from $30 to $33.
benzinga.com Wells Fargo Maintains Overweight on Enovis, Raises Price Target to $37 Wells Fargo analyst Larry Biegelsen maintains Enovis (NYSE:ENOV) with a Overweight and raises the price target from $33 to $37.
seekingalpha.com Enovis Corporation (ENOV) Q3 2026 Earnings Call Transcript Enovis Corporation ( ENOV ) Q3 2026 Earnings Call November 5, 2026 8:30 AM EST Company Participants Kyle Rose - Vice President of Investor Relations Damien McDonald - CEO & Director Phillip Berry -…
benzinga.com Enovis Q3 2026 Earnings Call Transcript Enovis (NYSE:ENOV) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
zacks.com Enovis (ENOV) Q3 Earnings and Revenues Beat Estimates Enovis (ENOV) came out with quarterly earnings of $0.88 per share, beating the Zacks Consensus Estimate of $0.76 per share. This compares to earnings of $0.75 per share a year ago.benzinga.com Enovis Q3 Adj. EPS $0.88 Beats $0.77 Estimate, Sales $558.725M Beat $557.010M Estimate Enovis (NYSE:ENOV) reported quarterly earnings of $0.88 per share which beat the analyst consensus estimate of $0.77 by 14.29 percent. This is a 17.33 percent increase over earnings of $0.75 per…
benzinga.com Enovis Raises FY2026 Adj EPS Guidance from $3.52-$3.73 to $3.58-$3.79 vs $3.63 Est; Narrows FY2026 Sales Guidance from $2.310B-$2.370B to $2.320B-$2.350B vs $2.339B Est Enovis (NYSE:ENOV) raises FY2026 Adj EPS guidance from $3.52-$3.73 to $3.58-$3.79 vs $3.63 analyst estimate. Narrows FY2026 sales outlook from $2.310 billion-$2.370 billion to $2.320 billion-$2.350…
globenewswire.com ENOVIS Announces Third Quarter 2026 Results Dallas, TX, Nov. 05, 2026 (GLOBE NEWSWIRE) -- - Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial…
globenewswire.com Enovis to Host Third Quarter 2026 Results Conference Call on November 5th Dallas, TX, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and…
defenseworld.net electroCore (NASDAQ:ECOR) and Enovis (NYSE:ENOV) Head-To-Head Comparison electroCore (NASDAQ: ECOR - Get Free Report) and Enovis (NYSE: ENOV - Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two…
defenseworld.net Critical Survey: Enovis (NYSE:ENOV) vs. Nexalin Technology (NASDAQ:NXL) Nexalin Technology (NASDAQ: NXL - Get Free Report) and Enovis (NYSE: ENOV - Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two…
prnewswire.com Enovis becomes first multi-registry industry sponsor of AAOS Registry Program Company expands its support from the American Joint Replacement Registry to include the Shoulder & Elbow Registry ROSEMONT, Ill., Sept. 22, 2026 /PRNewswire/ -- The American Academy of Orthopaedic…
defenseworld.net Enovis (NYSE:ENOV) Hits New 52-Week Low – What’s Next? Enovis Corporation (NYSE: ENOV - Get Free Report)'s share price reached a new 52-week low during mid-day trading on Wednesday. The stock traded as low as $17.30 and last traded at $17.9220, with a…
fool.com Insider at Medical Device Maker Buys More Than 7,500 Shares Engert's $150,000 purchase represents a 14% increase to his direct holdings, signaling confidence despite stock's -37% one-year decline.
zacks.com What Makes Enovis (ENOV) a New Buy Stock Enovis (ENOV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
zacks.com Enovis (ENOV) Loses 33% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Enovis (ENOV) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising…
zacks.com Enovis Boosts Surgical Robotics Portfolio With eCential Acquisition ENOV is set to acquire eCential Robotics to expand into orthopedic surgical robotics, though the deal is expected to pressure 2027 margins.
seekingalpha.com Enovis Corporation (ENOV) M&A Call Transcript Enovis Corporation (ENOV) M&A Call Transcript
marketbeat.com Enovis Targets Robotic Surgery Expansion With €155M eCential Robotics Deal Enovis NYSE: ENOV said it has entered a binding offer to acquire eCential Robotics, a developer of surgical robotics technology, in a move the orthopedic company said will expand its…
prnewswire.com eCential Robotics Announces Binding Offer from Enovis eCential Robotics platform to join Enovis' enabling technology portfolio. GRENOBLE, France and FRANKLIN, Tenn.
globenewswire.com Enovis Invests in Innovation with Binding Offer to Acquire eCential Robotics, a Leading Developer of Enabling Technologies and Surgical Robotics Dallas, TX, Sept. 01, 2026 (GLOBE NEWSWIRE) -- – Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced today that it has entered into a binding offer to acquire…
globenewswire.com Enovis to Participate in the 2026 Wells Fargo Healthcare Conference Dallas, TX, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it will participate in the 2026 Wells…
seekingalpha.com Enovis Corporation: Arvis Is Disrupting The Health Care Industry Enovis Corporation is rated a buy, trading at a 7x EBITDA multiple versus a sector median of 14.7x, with significant upside if Arvis succeeds. Arvis, a zero-footprint, wearable augmented reality…
